Dr. Francesco Marincola Appointed as Chairman of Batu Biologics Clinical Advisory Board

Pioneer of Tumor Immunotherapy Dr. Francesco Marincola Appointed as Chairman of Batu Biologics Clinical Advisory Board

Former President of the Society for Immunotherapy of Cancer to Assist Company in Advancement of its Anti-Angiogenesis Immunotherapy Product ValloVax

Batu Biologics, committed to advancement of its clinical stage cancer immunotherapeutic, ValloVax™, announced today the appointment of Dr. Francesco Marincola as the Chairman of the Company’s Clinical Advisory Board.

Read the full article at businesswire.com

Continue →
0

Batu Biologics CEO to Moderate Congressional Immunotherapy Symposium

Batu Biologics Chief Executive Officer Samuel Wagner to Moderate Congressional Immunotherapy Symposium

Congressional Candidate to Hear Concerns of Industry Leaders in Health Care Innovations

Batu Biologics, a clinical stage immunotherapy company, announced today its Chief Executive Officer, Samuel Wagner, was chosen to moderate an internationally renowned panel of biotechnology companies focusing on immunotherapy.

Read the full article at businesswire.com

Continue →
0

Batu Biologics CEO Selected for Lyfebulb Oncology Award

Batu Biologics CEO Selected as Finalist for Lyfebulb-Helsinn Innovation Summit and Award For Oncology

Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology

Lyfebulb, a patient empowerment platform that connects patients, industry and investors to support user-driven innovation in chronic diseases, and Helsinn, today announced the names of the eleven companies launched by patient entrepreneurs who are chosen as finalists for the Lyfebulb-Helsinn Innovation Summit & Award in Oncology.

Read the full article at globalnewswire.com

Continue →
0